{"id":"https://openalex.org/W3045004415","doi":"https://doi.org/10.1021/acs.jmedchem.0c00614","title":"GSK789: A Selective Inhibitor of the First Bromodomains (BD1) of the Bromo and Extra Terminal Domain (BET) Proteins","display_name":"GSK789: A Selective Inhibitor of the First Bromodomains (BD1) of the Bromo and Extra Terminal Domain (BET) Proteins","alternate_titles":[],"publication_year":2020,"publication_date":"2020-07-21","ids":{"openalex":"https://openalex.org/W3045004415","doi":"https://doi.org/10.1021/acs.jmedchem.0c00614","mag":"3045004415","pmid":"https://pubmed.ncbi.nlm.nih.gov/32691589"},"language":"en","primary_location":{"id":"doi:10.1021/acs.jmedchem.0c00614","doi":"https://doi.org/10.1021/acs.jmedchem.0c00614","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.0c00614","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3045004415"],"child_works_count":2,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000546994","display_name":"Robert J. Watson","orcid":"https://orcid.org/0000-0003-3146-3457","observed_orcids":["https://orcid.org/0000-0003-3146-3457"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robert J. Watson","raw_affiliation_strings":["Epigenetics Discovery Performance Unit, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epigenetics Discovery Performance Unit, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011795002","display_name":"Paul Bamborough","orcid":"https://orcid.org/0000-0001-9479-2894","observed_orcids":["https://orcid.org/0000-0001-9479-2894"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Paul Bamborough","raw_affiliation_strings":["Molecular Discovery Research, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K"],"raw_orcid":"https://orcid.org/0000-0001-9479-2894","affiliations":[{"raw_affiliation_string":"Molecular Discovery Research, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Heather Barnett","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Heather Barnett","raw_affiliation_strings":["Flexible Discovery Unit, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Flexible Discovery Unit, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059463978","display_name":"Chun\u2010wa Chung","orcid":"https://orcid.org/0000-0002-2480-3110","observed_orcids":["https://orcid.org/0000-0002-2480-3110"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Chun-wa Chung","raw_affiliation_strings":["Molecular Discovery Research, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K"],"raw_orcid":"https://orcid.org/0000-0002-2480-3110","affiliations":[{"raw_affiliation_string":"Molecular Discovery Research, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019088409","display_name":"Rob P. Davis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rob Davis","raw_affiliation_strings":["Epigenetics Discovery Performance Unit, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epigenetics Discovery Performance Unit, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002254682","display_name":"Laurie J. Gordon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Laurie Gordon","raw_affiliation_strings":["Molecular Discovery Research, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Discovery Research, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015681234","display_name":"Paola Grandi","orcid":"https://orcid.org/0000-0002-6337-1269","observed_orcids":["https://orcid.org/0000-0002-6337-1269"]},"institutions":[{"id":"https://openalex.org/I4210148983","display_name":"GlaxoSmithKline (Germany)","ror":"https://ror.org/05gedqb32","country_code":"DE","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210148983"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paola Grandi","raw_affiliation_strings":["Molecular Discovery Research, GlaxoSmithKline, Cellzome GmbH, Meyerhofstrasse 1, 69117 Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Discovery Research, GlaxoSmithKline, Cellzome GmbH, Meyerhofstrasse 1, 69117 Heidelberg, Germany","institution_ids":["https://openalex.org/I4210148983"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010756117","display_name":"M. Petretich","orcid":"https://orcid.org/0000-0001-7486-8222","observed_orcids":["https://orcid.org/0000-0001-7486-8222"]},"institutions":[{"id":"https://openalex.org/I4210148983","display_name":"GlaxoSmithKline (Germany)","ror":"https://ror.org/05gedqb32","country_code":"DE","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210148983"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Massimo Petretich","raw_affiliation_strings":["Molecular Discovery Research, GlaxoSmithKline, Cellzome GmbH, Meyerhofstrasse 1, 69117 Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Discovery Research, GlaxoSmithKline, Cellzome GmbH, Meyerhofstrasse 1, 69117 Heidelberg, Germany","institution_ids":["https://openalex.org/I4210148983"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070416732","display_name":"Alex Phillipou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alex Phillipou","raw_affiliation_strings":["Molecular Discovery Research, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Discovery Research, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029447427","display_name":"Rab K. Prinjha","orcid":"https://orcid.org/0000-0002-2666-3326","observed_orcids":["https://orcid.org/0000-0002-2666-3326"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rab K. Prinjha","raw_affiliation_strings":["Epigenetics Discovery Performance Unit, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epigenetics Discovery Performance Unit, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068014083","display_name":"Inmaculada Rioja","orcid":"https://orcid.org/0000-0002-0533-2253","observed_orcids":["https://orcid.org/0000-0002-0533-2253"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Inmaculada Rioja","raw_affiliation_strings":["Epigenetics Discovery Performance Unit, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epigenetics Discovery Performance Unit, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084163133","display_name":"Peter E. Soden","orcid":"https://orcid.org/0000-0001-7757-9354","observed_orcids":["https://orcid.org/0000-0001-7757-9354"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter Soden","raw_affiliation_strings":["Epigenetics Discovery Performance Unit, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epigenetics Discovery Performance Unit, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044434183","display_name":"Thilo Werner","orcid":"https://orcid.org/0000-0003-0688-5834","observed_orcids":["https://orcid.org/0000-0003-0688-5834"]},"institutions":[{"id":"https://openalex.org/I4210148983","display_name":"GlaxoSmithKline (Germany)","ror":"https://ror.org/05gedqb32","country_code":"DE","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210148983"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Thilo Werner","raw_affiliation_strings":["Molecular Discovery Research, GlaxoSmithKline, Cellzome GmbH, Meyerhofstrasse 1, 69117 Heidelberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Discovery Research, GlaxoSmithKline, Cellzome GmbH, Meyerhofstrasse 1, 69117 Heidelberg, Germany","institution_ids":["https://openalex.org/I4210148983"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009737267","display_name":"Emmanuel H. Demont","orcid":"https://orcid.org/0000-0001-7307-3129","observed_orcids":["https://orcid.org/0000-0001-7307-3129"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Emmanuel H. Demont","raw_affiliation_strings":["Epigenetics Discovery Performance Unit, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K"],"raw_orcid":"https://orcid.org/0000-0001-7307-3129","affiliations":[{"raw_affiliation_string":"Epigenetics Discovery Performance Unit, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K","institution_ids":["https://openalex.org/I188950975"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5009737267","https://openalex.org/A5011795002"],"corresponding_institution_ids":["https://openalex.org/I188950975"],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":3.9378,"has_fulltext":false,"cited_by_count":103,"citation_normalized_percentile":{"value":0.95896438,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"63","issue":"17","first_page":"9045","last_page":"9069"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bet-proteins","display_name":"BET proteins","score":0.7689999938011169},{"id":"https://openalex.org/keywords/bromodomain-inhibitors","display_name":"bromodomain inhibitors","score":0.8399999737739563},{"id":"https://openalex.org/keywords/selective-inhibition","display_name":"selective inhibition","score":0.6060000061988831},{"id":"https://openalex.org/keywords/cell-permeable-inhibitors","display_name":"cell-permeable inhibitors","score":0.6990000009536743},{"id":"https://openalex.org/keywords/immunomodulation","display_name":"immunomodulation","score":0.921999990940094},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.4560000002384186}],"concepts":[{"id":"https://openalex.org/C74401373","wikidata":"https://www.wikidata.org/wiki/Q1829843","display_name":"Bromodomain","level":4,"score":0.9900995492935181},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7337967753410339},{"id":"https://openalex.org/C2780862049","wikidata":"https://www.wikidata.org/wiki/Q25326844","display_name":"BET inhibitor","level":5,"score":0.6210530996322632},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5686848163604736},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5593530535697937},{"id":"https://openalex.org/C2779634854","wikidata":"https://www.wikidata.org/wiki/Q18037206","display_name":"BRD4","level":5,"score":0.4434422552585602},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4332490861415863},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2654975652694702},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.12687748670578003},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.11592862010002136},{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.11529242992401123},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0796811580657959}],"mesh":[{"descriptor_ui":"D000072417","descriptor_name":"Protein Domains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000074183","descriptor_name":"ATPases Associated with Diverse Cellular Activities","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D000074183","descriptor_name":"ATPases Associated with Diverse Cellular Activities","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000092468","descriptor_name":"Bromodomain Containing Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D001665","descriptor_name":"Binding Sites","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004268","descriptor_name":"DNA-Binding Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D004268","descriptor_name":"DNA-Binding Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009287","descriptor_name":"Naphthyridines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009287","descriptor_name":"Naphthyridines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009287","descriptor_name":"Naphthyridines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D014157","descriptor_name":"Transcription Factors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D014157","descriptor_name":"Transcription Factors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D018360","descriptor_name":"Crystallography, X-Ray","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018797","descriptor_name":"Cell Cycle Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D018797","descriptor_name":"Cell Cycle Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D056004","descriptor_name":"Molecular Dynamics Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/acs.jmedchem.0c00614","doi":"https://doi.org/10.1021/acs.jmedchem.0c00614","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.jmedchem.0c00614","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:32691589","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32691589","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.766700029373169,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":55,"referenced_works":["https://openalex.org/W984132521","https://openalex.org/W1516646538","https://openalex.org/W1827840064","https://openalex.org/W1966585118","https://openalex.org/W1968827652","https://openalex.org/W1976033223","https://openalex.org/W1982438274","https://openalex.org/W1988335148","https://openalex.org/W1990174038","https://openalex.org/W1993186884","https://openalex.org/W2001619812","https://openalex.org/W2027275928","https://openalex.org/W2030737610","https://openalex.org/W2032365395","https://openalex.org/W2034080889","https://openalex.org/W2036146808","https://openalex.org/W2038840577","https://openalex.org/W2041535798","https://openalex.org/W2043532159","https://openalex.org/W2047790609","https://openalex.org/W2048964430","https://openalex.org/W2089259281","https://openalex.org/W2091368230","https://openalex.org/W2109790992","https://openalex.org/W2110808180","https://openalex.org/W2112067801","https://openalex.org/W2141091064","https://openalex.org/W2143660875","https://openalex.org/W2144081223","https://openalex.org/W2148934211","https://openalex.org/W2155958514","https://openalex.org/W2168229944","https://openalex.org/W2227664819","https://openalex.org/W2231123713","https://openalex.org/W2491205940","https://openalex.org/W2559922927","https://openalex.org/W2568322231","https://openalex.org/W2592276570","https://openalex.org/W2593764076","https://openalex.org/W2889751512","https://openalex.org/W2892851404","https://openalex.org/W2912500408","https://openalex.org/W2949995906","https://openalex.org/W2953873379","https://openalex.org/W2978021631","https://openalex.org/W2978679035","https://openalex.org/W2984431814","https://openalex.org/W2989678852","https://openalex.org/W3001038414","https://openalex.org/W3011089475","https://openalex.org/W3044199686","https://openalex.org/W3045152887","https://openalex.org/W3047589966","https://openalex.org/W4238222281","https://openalex.org/W4248872320"],"related_works":["https://openalex.org/W3039459629","https://openalex.org/W3045152887","https://openalex.org/W3047589966","https://openalex.org/W3178466412","https://openalex.org/W3044199686","https://openalex.org/W4244592690","https://openalex.org/W4220998638","https://openalex.org/W3019959100","https://openalex.org/W7166663297","https://openalex.org/W2989678852"],"abstract_inverted_index":{"Pan-bromodomain":[0],"and":[1,25,30,33,70,78,87],"extra":[2],"terminal":[3],"(BET)":[4],"inhibitors":[5],"interact":[6],"equipotently":[7],"with":[8],"all":[9],"eight":[10],"bromodomains":[11,94],"of":[12,16,36,59,82,91,95],"the":[13,56,64,75,92,96],"BET":[14,97],"family":[15],"proteins.":[17],"They":[18],"have":[19,47],"shown":[20],"profound":[21],"efficacy":[22,69],"in":[23,26,28,40,76],"vitro":[24,77],"vivo":[27],"oncology":[29],"immunomodulatory":[31],"models,":[32],"a":[34,84],"number":[35],"them":[37],"are":[38],"currently":[39],"clinical":[41],"trials":[42],"where":[43],"significant":[44],"safety":[45],"signals":[46],"been":[48],"reported.":[49],"It":[50],"is":[51],"therefore":[52],"important":[53],"to":[54,62,66],"understand":[55],"functional":[57],"contribution":[58],"each":[60],"bromodomain":[61],"assess":[63],"opportunity":[65],"tease":[67],"apart":[68],"toxicity.":[71],"This":[72],"article":[73],"discloses":[74],"cellular":[79],"activity":[80],"profiles":[81],"GSK789,":[83],"potent,":[85],"cell-permeable,":[86],"highly":[88],"selective":[89],"inhibitor":[90],"first":[93],"family.":[98]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3045004415","counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":22},{"year":2024,"cited_by_count":13},{"year":2023,"cited_by_count":19},{"year":2022,"cited_by_count":19},{"year":2021,"cited_by_count":19},{"year":2020,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2020-07-29T00:00:00"}
